0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Over-the-Counter Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-32K13310
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Over the Counter Drugs Market Research Report 2023
BUY CHAPTERS

Over-the-Counter Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32K13310
Report
September 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Over-the-Counter Drugs - Market Size

The global market for Over-the-Counter Drugs was estimated to be worth US$ 42040 million in 2023 and is forecast to a readjusted size of US$ 48990 million by 2030 with a CAGR of 1.8% during the forecast period 2024-2030

Over-the-Counter Drugs - Market

Over-the-Counter Drugs - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Over-the-Counter Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Over-the-Counter Drugs by region & country, by Type, and by Application.
The Over-the-Counter Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over-the-Counter Drugs.
Market Segmentation

Scope of Over-the-Counter Drugs - Market Report

Report Metric Details
Report Name Over-the-Counter Drugs - Market
Forecasted market size in 2030 US$ 48990 million
CAGR 1.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Analgesics & Pain Relievers
  • Cough, Cold and Flu Products
  • Dermatological Products
  • Vitamin & Mineral Supplements
  • Gastrointestinal Products
  • Sleep Aids
  • Weight Loss Products
  • Smoking Cession Aids
  • Ophthalmic Products
  • Other
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, GlaxoSmithKline, Boehringer Ingelheim, Bayer, Alkem Laboratories, Glenmark Pharmaceuticals, Cipla
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Over-the-Counter Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Over-the-Counter Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Over-the-Counter Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Over-the-Counter Drugs - Market size in 2030?

Ans: The Over-the-Counter Drugs - Market size in 2030 will be US$ 48990 million.

Who are the main players in the Over-the-Counter Drugs - Market report?

Ans: The main players in the Over-the-Counter Drugs - Market are Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, GlaxoSmithKline, Boehringer Ingelheim, Bayer, Alkem Laboratories, Glenmark Pharmaceuticals, Cipla

What are the Application segmentation covered in the Over-the-Counter Drugs - Market report?

Ans: The Applications covered in the Over-the-Counter Drugs - Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Over-the-Counter Drugs - Market report?

Ans: The Types covered in the Over-the-Counter Drugs - Market report are Analgesics & Pain Relievers, Cough, Cold and Flu Products, Dermatological Products, Vitamin & Mineral Supplements, Gastrointestinal Products, Sleep Aids, Weight Loss Products, Smoking Cession Aids, Ophthalmic Products, Other

1 Market Overview
1.1 Over-the-Counter Drugs Product Introduction
1.2 Global Over-the-Counter Drugs Market Size Forecast
1.3 Over-the-Counter Drugs Market Trends & Drivers
1.3.1 Over-the-Counter Drugs Industry Trends
1.3.2 Over-the-Counter Drugs Market Drivers & Opportunity
1.3.3 Over-the-Counter Drugs Market Challenges
1.3.4 Over-the-Counter Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Over-the-Counter Drugs Players Revenue Ranking (2023)
2.2 Global Over-the-Counter Drugs Revenue by Company (2019-2024)
2.3 Key Companies Over-the-Counter Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Over-the-Counter Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Over-the-Counter Drugs
2.6 Over-the-Counter Drugs Market Competitive Analysis
2.6.1 Over-the-Counter Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Over-the-Counter Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-the-Counter Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Analgesics & Pain Relievers
3.1.2 Cough, Cold and Flu Products
3.1.3 Dermatological Products
3.1.4 Vitamin & Mineral Supplements
3.1.5 Gastrointestinal Products
3.1.6 Sleep Aids
3.1.7 Weight Loss Products
3.1.8 Smoking Cession Aids
3.1.9 Ophthalmic Products
3.1.10 Other
3.2 Global Over-the-Counter Drugs Sales Value by Type
3.2.1 Global Over-the-Counter Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Over-the-Counter Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Over-the-Counter Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Over-the-Counter Drugs Sales Value by Application
4.2.1 Global Over-the-Counter Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Over-the-Counter Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Over-the-Counter Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Over-the-Counter Drugs Sales Value by Region
5.1.1 Global Over-the-Counter Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Over-the-Counter Drugs Sales Value by Region (2019-2024)
5.1.3 Global Over-the-Counter Drugs Sales Value by Region (2025-2030)
5.1.4 Global Over-the-Counter Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Over-the-Counter Drugs Sales Value, 2019-2030
5.2.2 North America Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Over-the-Counter Drugs Sales Value, 2019-2030
5.3.2 Europe Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Over-the-Counter Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Over-the-Counter Drugs Sales Value, 2019-2030
5.5.2 South America Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Over-the-Counter Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Over-the-Counter Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Over-the-Counter Drugs Sales Value
6.3 United States
6.3.1 United States Over-the-Counter Drugs Sales Value, 2019-2030
6.3.2 United States Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Over-the-Counter Drugs Sales Value, 2019-2030
6.4.2 Europe Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Over-the-Counter Drugs Sales Value, 2019-2030
6.5.2 China Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Over-the-Counter Drugs Sales Value, 2019-2030
6.6.2 Japan Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Over-the-Counter Drugs Sales Value, 2019-2030
6.7.2 South Korea Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Over-the-Counter Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Over-the-Counter Drugs Sales Value, 2019-2030
6.9.2 India Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Over-the-Counter Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Profile
7.1.2 Johnson & Johnson Main Business
7.1.3 Johnson & Johnson Over-the-Counter Drugs Products, Services and Solutions
7.1.4 Johnson & Johnson Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Johnson & Johnson Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Over-the-Counter Drugs Products, Services and Solutions
7.2.4 Merck Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Novartis
7.3.1 Novartis Profile
7.3.2 Novartis Main Business
7.3.3 Novartis Over-the-Counter Drugs Products, Services and Solutions
7.3.4 Novartis Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Pfizer Recent Developments
7.4 Pfizer
7.4.1 Pfizer Profile
7.4.2 Pfizer Main Business
7.4.3 Pfizer Over-the-Counter Drugs Products, Services and Solutions
7.4.4 Pfizer Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Pfizer Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Over-the-Counter Drugs Products, Services and Solutions
7.5.4 Sanofi Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Profile
7.6.2 Teva Pharmaceutical Industries Main Business
7.6.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Products, Services and Solutions
7.6.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Teva Pharmaceutical Industries Recent Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Profile
7.7.2 Sun Pharmaceutical Industries Main Business
7.7.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Products, Services and Solutions
7.7.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 Sun Pharmaceutical Industries Recent Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Profile
7.8.2 GlaxoSmithKline Main Business
7.8.3 GlaxoSmithKline Over-the-Counter Drugs Products, Services and Solutions
7.8.4 GlaxoSmithKline Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Recent Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Profile
7.9.2 Boehringer Ingelheim Main Business
7.9.3 Boehringer Ingelheim Over-the-Counter Drugs Products, Services and Solutions
7.9.4 Boehringer Ingelheim Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 Boehringer Ingelheim Recent Developments
7.10 Bayer
7.10.1 Bayer Profile
7.10.2 Bayer Main Business
7.10.3 Bayer Over-the-Counter Drugs Products, Services and Solutions
7.10.4 Bayer Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 Bayer Recent Developments
7.11 Alkem Laboratories
7.11.1 Alkem Laboratories Profile
7.11.2 Alkem Laboratories Main Business
7.11.3 Alkem Laboratories Over-the-Counter Drugs Products, Services and Solutions
7.11.4 Alkem Laboratories Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.11.5 Alkem Laboratories Recent Developments
7.12 Glenmark Pharmaceuticals
7.12.1 Glenmark Pharmaceuticals Profile
7.12.2 Glenmark Pharmaceuticals Main Business
7.12.3 Glenmark Pharmaceuticals Over-the-Counter Drugs Products, Services and Solutions
7.12.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.12.5 Glenmark Pharmaceuticals Recent Developments
7.13 Cipla
7.13.1 Cipla Profile
7.13.2 Cipla Main Business
7.13.3 Cipla Over-the-Counter Drugs Products, Services and Solutions
7.13.4 Cipla Over-the-Counter Drugs Revenue (US$ Million) & (2019-2024)
7.13.5 Cipla Recent Developments
8 Industry Chain Analysis
8.1 Over-the-Counter Drugs Industrial Chain
8.2 Over-the-Counter Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Over-the-Counter Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Over-the-Counter Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Over-the-Counter Drugs Market Trends
    Table 2. Over-the-Counter Drugs Market Drivers & Opportunity
    Table 3. Over-the-Counter Drugs Market Challenges
    Table 4. Over-the-Counter Drugs Market Restraints
    Table 5. Global Over-the-Counter Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Over-the-Counter Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Over-the-Counter Drugs Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Over-the-Counter Drugs Product Type
    Table 9. Key Companies Time to Begin Mass Production of Over-the-Counter Drugs
    Table 10. Global Over-the-Counter Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-the-Counter Drugs as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Over-the-Counter Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Over-the-Counter Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Over-the-Counter Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Over-the-Counter Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Over-the-Counter Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Over-the-Counter Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Over-the-Counter Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Over-the-Counter Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Over-the-Counter Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Over-the-Counter Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Over-the-Counter Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Over-the-Counter Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Over-the-Counter Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Over-the-Counter Drugs Sales Value by Region (2019-2024) & (%)
    Table 27. Global Over-the-Counter Drugs Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Over-the-Counter Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Over-the-Counter Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Over-the-Counter Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 31. Johnson & Johnson Basic Information List
    Table 32. Johnson & Johnson Description and Business Overview
    Table 33. Johnson & Johnson Over-the-Counter Drugs Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Over-the-Counter Drugs Business of Johnson & Johnson (2019-2024)
    Table 35. Johnson & Johnson Recent Developments
    Table 36. Merck Basic Information List
    Table 37. Merck Description and Business Overview
    Table 38. Merck Over-the-Counter Drugs Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Over-the-Counter Drugs Business of Merck (2019-2024)
    Table 40. Merck Recent Developments
    Table 41. Novartis Basic Information List
    Table 42. Novartis Description and Business Overview
    Table 43. Novartis Over-the-Counter Drugs Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Over-the-Counter Drugs Business of Novartis (2019-2024)
    Table 45. Novartis Recent Developments
    Table 46. Pfizer Basic Information List
    Table 47. Pfizer Description and Business Overview
    Table 48. Pfizer Over-the-Counter Drugs Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Over-the-Counter Drugs Business of Pfizer (2019-2024)
    Table 50. Pfizer Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi Over-the-Counter Drugs Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Over-the-Counter Drugs Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. Teva Pharmaceutical Industries Basic Information List
    Table 57. Teva Pharmaceutical Industries Description and Business Overview
    Table 58. Teva Pharmaceutical Industries Over-the-Counter Drugs Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Over-the-Counter Drugs Business of Teva Pharmaceutical Industries (2019-2024)
    Table 60. Teva Pharmaceutical Industries Recent Developments
    Table 61. Sun Pharmaceutical Industries Basic Information List
    Table 62. Sun Pharmaceutical Industries Description and Business Overview
    Table 63. Sun Pharmaceutical Industries Over-the-Counter Drugs Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Over-the-Counter Drugs Business of Sun Pharmaceutical Industries (2019-2024)
    Table 65. Sun Pharmaceutical Industries Recent Developments
    Table 66. GlaxoSmithKline Basic Information List
    Table 67. GlaxoSmithKline Description and Business Overview
    Table 68. GlaxoSmithKline Over-the-Counter Drugs Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Over-the-Counter Drugs Business of GlaxoSmithKline (2019-2024)
    Table 70. GlaxoSmithKline Recent Developments
    Table 71. Boehringer Ingelheim Basic Information List
    Table 72. Boehringer Ingelheim Description and Business Overview
    Table 73. Boehringer Ingelheim Over-the-Counter Drugs Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Over-the-Counter Drugs Business of Boehringer Ingelheim (2019-2024)
    Table 75. Boehringer Ingelheim Recent Developments
    Table 76. Bayer Basic Information List
    Table 77. Bayer Description and Business Overview
    Table 78. Bayer Over-the-Counter Drugs Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Over-the-Counter Drugs Business of Bayer (2019-2024)
    Table 80. Bayer Recent Developments
    Table 81. Alkem Laboratories Basic Information List
    Table 82. Alkem Laboratories Description and Business Overview
    Table 83. Alkem Laboratories Over-the-Counter Drugs Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Over-the-Counter Drugs Business of Alkem Laboratories (2019-2024)
    Table 85. Alkem Laboratories Recent Developments
    Table 86. Glenmark Pharmaceuticals Basic Information List
    Table 87. Glenmark Pharmaceuticals Description and Business Overview
    Table 88. Glenmark Pharmaceuticals Over-the-Counter Drugs Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Over-the-Counter Drugs Business of Glenmark Pharmaceuticals (2019-2024)
    Table 90. Glenmark Pharmaceuticals Recent Developments
    Table 91. Cipla Basic Information List
    Table 92. Cipla Description and Business Overview
    Table 93. Cipla Over-the-Counter Drugs Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Over-the-Counter Drugs Business of Cipla (2019-2024)
    Table 95. Cipla Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Over-the-Counter Drugs Downstream Customers
    Table 99. Over-the-Counter Drugs Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Over-the-Counter Drugs Product Picture
    Figure 2. Global Over-the-Counter Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Over-the-Counter Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Over-the-Counter Drugs Report Years Considered
    Figure 5. Global Over-the-Counter Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Over-the-Counter Drugs Revenue in 2023
    Figure 7. Over-the-Counter Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Analgesics & Pain Relievers Picture
    Figure 9. Cough, Cold and Flu Products Picture
    Figure 10. Dermatological Products Picture
    Figure 11. Vitamin & Mineral Supplements Picture
    Figure 12. Gastrointestinal Products Picture
    Figure 13. Sleep Aids Picture
    Figure 14. Weight Loss Products Picture
    Figure 15. Smoking Cession Aids Picture
    Figure 16. Ophthalmic Products Picture
    Figure 17. Other Picture
    Figure 18. Global Over-the-Counter Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Over-the-Counter Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 20. Product Picture of Hospital Pharmacies
    Figure 21. Product Picture of Retail Pharmacies
    Figure 22. Product Picture of Online Pharmacies
    Figure 23. Global Over-the-Counter Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Over-the-Counter Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. North America Over-the-Counter Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Over-the-Counter Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Over-the-Counter Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Over-the-Counter Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Over-the-Counter Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Over-the-Counter Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Over-the-Counter Drugs Sales Value (%), (2019-2030)
    Figure 36. United States Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 37. United States Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 38. United States Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 39. Europe Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Europe Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 41. Europe Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 42. China Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. China Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. China Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 45. Japan Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Japan Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. Japan Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. South Korea Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. South Korea Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. South Korea Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. Southeast Asia Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Southeast Asia Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 53. Southeast Asia Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 54. India Over-the-Counter Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 55. India Over-the-Counter Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 56. India Over-the-Counter Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 57. Over-the-Counter Drugs Industrial Chain
    Figure 58. Over-the-Counter Drugs Manufacturing Cost Structure
    Figure 59. Channels of Distribution (Direct Sales, and Distribution)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

OSZAR »